Literature DB >> 27577849

Between stigma and pink positivity: women's perceptions of social interactions during and after breast cancer treatment.

Diane Trusson1, Alison Pilnick1.   

Abstract

This study explores women's perceptions of social interaction during and after their treatment for early stage breast cancer. An analysis of interviews with 24 women between 6 months and 29 years post-diagnosis reveals that interactions can be influenced by conflicting public discourses surrounding breast cancer. For example, there is the continuing association of cancer with death and the resulting potential for a stigmatised identity. In contrast is the ultra-positive discourse around cancer survivorship, with breast cancer in particular being associated with pink campaigning and a push towards positive thinking. Participants described managing conversations during treatment; sometimes playing down their private suffering and presenting a positive (public) image rather than risk alienating support. After treatment they were encouraged to move on and get back to 'normal'. While other breast cancer patients and survivors were often good sources of support, there was also a danger of assuming that all experiences would be the same. We present data to illustrate that women often present public accounts that are driven by an expectation of positivity and fear of stigmatisation at all stages of breast cancer treatment and beyond.
© 2016 Foundation for the Sociology of Health & Illness.

Entities:  

Keywords:  breast cancer; social support; stigma

Mesh:

Year:  2016        PMID: 27577849     DOI: 10.1111/1467-9566.12486

Source DB:  PubMed          Journal:  Sociol Health Illn        ISSN: 0141-9889


  8 in total

1.  Does the Broaden-and-Build Theory Explain Reduction in Social Disruption After a Brief Relaxation Intervention for Women With Breast Cancer Undergoing Treatment?

Authors:  Hannah M Fisher; Chloe J Taub; Suzanne C Lechner; Aaron S Heller; David J Lee; Michael H Antoni
Journal:  Behav Ther       Date:  2022-04-19

2.  The Experiential Learning Pathway of Cancer Survivors as They Recover Their Lives Post-Treatment: A Qualitative Study.

Authors:  Karine Bilodeau; Cynthia Henriksen; Virginia Lee; Marie-France Vachon; Danielle Charpentier; Nathalie Folch; Jacinthe Pepin; Marie-Pascale Pomey; Lynda Piché; Nicolas Fernandez
Journal:  Glob Qual Nurs Res       Date:  2022-04-11

3.  Non-Communicable Diseases-Related Stigma: A Mixed-Methods Systematic Review.

Authors:  Sarju Sing Rai; Elena V Syurina; Ruth M H Peters; Annisa Ika Putri; Marjolein B M Zweekhorst
Journal:  Int J Environ Res Public Health       Date:  2020-09-12       Impact factor: 3.390

Review 4.  Impact of stigma and stigma-focused interventions on screening and treatment outcomes in cancer patients.

Authors:  Elizabeth O Akin-Odanye; Anisah J Husman
Journal:  Ecancermedicalscience       Date:  2021-10-25

5.  Mapping of Female Breast Cancer Incidence and Mortality Rates to Socioeconomic Factors Cohort: Path Diagram Analysis.

Authors:  Qiongle Peng; Xiaoling Ren
Journal:  Front Public Health       Date:  2022-02-01

6.  Men With a "Woman's Disease": Stigmatization of Male Breast Cancer Patients-A Mixed Methods Analysis.

Authors:  Evamarie Midding; Sarah Maria Halbach; Christoph Kowalski; Rainer Weber; Rachel Würstlein; Nicole Ernstmann
Journal:  Am J Mens Health       Date:  2018-09-15

7.  Body image transformation after breast cancer diagnosis and treatment in southern Thai women.

Authors:  Thanarpan Peerawong; Tharin Phenwan; Somrit Mahattanobon; Kandawsri Tulathamkij; Uraiwan Pattanasattayavong
Journal:  SAGE Open Med       Date:  2019-02-13

8.  Cancer patients' experiences with immune checkpoint modulators: A qualitative study.

Authors:  Kari Ala-Leppilampi; Natalie A Baker; Chris McKillop; Marcus O Butler; Lillian L Siu; Anna Spreafico; Albiruni R Abdul Razak; Anthony M Joshua; David Hogg; Philippe L Bedard; Natasha Leighl; Amit M Oza; Janet A Parsons; Aaron R Hansen
Journal:  Cancer Med       Date:  2020-03-02       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.